Caxton Associates (New York)’s AnaptysBio ANAB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20,413	Closed	-$684K	–	490
2024 Q3	$684K	Buy	+20,413	New	+$684K	0.03%	313
2024 Q1	–	Sell	-19,191	Closed	-$411K	–	455
2023 Q4	$411K	Buy	19,191 +4,296	+29%	+$92K	0.02%	348
2023 Q3	$268K	Buy	+14,895	New	+$268K	0.04%	316